- call +1-201-465-4211
- email sales@mrinsights.biz
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
Scope of the Report:
This report focuses on the Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics SA
Boehringer Ingelheim GmbH
Celltrion Inc.
Coherus BioSciences, Inc
Dr. Reddy’s Laboratories Ltd.
Genor BioPharma Co. Ltd
Intas Pharmaceuticals Limited
Novartis AG
Pfizer, Inc.
Reliance Life Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Market Segment by Applications, can be divided into
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
There are 15 Chapters to deeply display the global Biosimilar market.
Chapter 1, to describe Biosimilar Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biosimilar, with sales, revenue, and price of Biosimilar, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilar, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biosimilar sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Human Growth Hormones
1.2.2 Monoclonal Antibodies
1.2.3 Insulin
1.2.4 Peptides
1.2.5 Erythropoietin
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Chronic and Autoimmune Diseases
1.3.3 Growth Hormone Deficiency
1.3.4 Infectious Diseases
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan plc
2.1.1 Business Overview
2.1.2 Biosimilar Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 BIOCAD
2.2.1 Business Overview
2.2.2 Biosimilar Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocon
2.3.1 Business Overview
2.3.2 Biosimilar Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BioXpress Therapeutics SA
2.4.1 Business Overview
2.4.2 Biosimilar Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim GmbH
2.5.1 Business Overview
2.5.2 Biosimilar Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Celltrion Inc.
2.6.1 Business Overview
2.6.2 Biosimilar Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Coherus BioSciences, Inc
2.7.1 Business Overview
2.7.2 Biosimilar Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Dr. Reddy’s Laboratories Ltd.
2.8.1 Business Overview
2.8.2 Biosimilar Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dr. Reddy’s Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Genor BioPharma Co. Ltd
2.9.1 Business Overview
2.9.2 Biosimilar Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Intas Pharmaceuticals Limited
2.10.1 Business Overview
2.10.2 Biosimilar Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Novartis AG
2.11.1 Business Overview
2.11.2 Biosimilar Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novartis AG Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Pfizer, Inc.
2.12.1 Business Overview
2.12.2 Biosimilar Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Pfizer, Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Reliance Life Sciences
2.13.1 Business Overview
2.13.2 Biosimilar Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Reliance Life Sciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biosimilar Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Biosimilar Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biosimilar Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilar Manufacturer Market Share in 2017
3.3.2 Top 6 Biosimilar Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Biosimilar Market Analysis by Regions
4.1 Global Biosimilar Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Sales and Market Share by Regions (2013-2018)
4.1.2 Global Biosimilar Revenue and Market Share by Regions (2013-2018)
4.2 North America Biosimilar Sales and Growth Rate (2013-2018)
4.3 Europe Biosimilar Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilar Sales and Growth Rate (2013-2018)
4.5 South America Biosimilar Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilar Sales and Growth Rate (2013-2018)
5 North America Biosimilar by Countries
5.1 North America Biosimilar Sales, Revenue and Market Share by Countries
5.1.1 North America Biosimilar Sales and Market Share by Countries (2013-2018)
5.1.2 North America Biosimilar Revenue and Market Share by Countries (2013-2018)
5.2 United States Biosimilar Sales and Growth Rate (2013-2018)
5.3 Canada Biosimilar Sales and Growth Rate (2013-2018)
5.4 Mexico Biosimilar Sales and Growth Rate (2013-2018)
6 Europe Biosimilar by Countries
6.1 Europe Biosimilar Sales, Revenue and Market Share by Countries
6.1.1 Europe Biosimilar Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Biosimilar Revenue and Market Share by Countries (2013-2018)
6.2 Germany Biosimilar Sales and Growth Rate (2013-2018)
6.3 UK Biosimilar Sales and Growth Rate (2013-2018)
6.4 France Biosimilar Sales and Growth Rate (2013-2018)
6.5 Russia Biosimilar Sales and Growth Rate (2013-2018)
6.6 Italy Biosimilar Sales and Growth Rate (2013-2018)
7 Asia-Pacific Biosimilar by Countries
7.1 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biosimilar Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Biosimilar Revenue and Market Share by Countries (2013-2018)
7.2 China Biosimilar Sales and Growth Rate (2013-2018)
7.3 Japan Biosimilar Sales and Growth Rate (2013-2018)
7.4 Korea Biosimilar Sales and Growth Rate (2013-2018)
7.5 India Biosimilar Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Biosimilar Sales and Growth Rate (2013-2018)
8 South America Biosimilar by Countries
8.1 South America Biosimilar Sales, Revenue and Market Share by Countries
8.1.1 South America Biosimilar Sales and Market Share by Countries (2013-2018)
8.1.2 South America Biosimilar Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Biosimilar Sales and Growth Rate (2013-2018)
8.3 Argentina Biosimilar Sales and Growth Rate (2013-2018)
8.4 Colombia Biosimilar Sales and Growth Rate (2013-2018)
9 Middle East and Africa Biosimilar by Countries
9.1 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biosimilar Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Biosimilar Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Biosimilar Sales and Growth Rate (2013-2018)
9.3 UAE Biosimilar Sales and Growth Rate (2013-2018)
9.4 Egypt Biosimilar Sales and Growth Rate (2013-2018)
9.5 Nigeria Biosimilar Sales and Growth Rate (2013-2018)
9.6 South Africa Biosimilar Sales and Growth Rate (2013-2018)
10 Global Biosimilar Market Segment by Type
10.1 Global Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biosimilar Sales and Market Share by Type (2013-2018)
10.1.2 Global Biosimilar Revenue and Market Share by Type (2013-2018)
10.2 Human Growth Hormones Sales Growth and Price
10.2.1 Global Human Growth Hormones Sales Growth (2013-2018)
10.2.2 Global Human Growth Hormones Price (2013-2018)
10.3 Monoclonal Antibodies Sales Growth and Price
10.3.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.3.2 Global Monoclonal Antibodies Price (2013-2018)
10.4 Insulin Sales Growth and Price
10.4.1 Global Insulin Sales Growth (2013-2018)
10.4.2 Global Insulin Price (2013-2018)
10.5 Peptides Sales Growth and Price
10.5.1 Global Peptides Sales Growth (2013-2018)
10.5.2 Global Peptides Price (2013-2018)
10.6 Erythropoietin Sales Growth and Price
10.6.1 Global Erythropoietin Sales Growth (2013-2018)
10.6.2 Global Erythropoietin Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Biosimilar Market Segment by Application
11.1 Global Biosimilar Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Chronic and Autoimmune Diseases Sales Growth (2013-2018)
11.4 Growth Hormone Deficiency Sales Growth (2013-2018)
11.5 Infectious Diseases Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Biosimilar Market Forecast (2018-2023)
12.1 Global Biosimilar Sales, Revenue and Growth Rate (2018-2023)
12.2 Biosimilar Market Forecast by Regions (2018-2023)
12.2.1 North America Biosimilar Market Forecast (2018-2023)
12.2.2 Europe Biosimilar Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biosimilar Market Forecast (2018-2023)
12.2.4 South America Biosimilar Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biosimilar Market Forecast (2018-2023)
12.3 Biosimilar Market Forecast by Type (2018-2023)
12.3.1 Global Biosimilar Sales Forecast by Type (2018-2023)
12.3.2 Global Biosimilar Market Share Forecast by Type (2018-2023)
12.4 Biosimilar Market Forecast by Application (2018-2023)
12.4.1 Global Biosimilar Sales Forecast by Application (2018-2023)
12.4.2 Global Biosimilar Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Biosimilar Picture
Table Product Specifications of Biosimilar
Figure Global Sales Market Share of Biosimilar by Types in 2017
Table Biosimilar Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
